Thousands more patients to access second ground-breaking antiviral
Thousands more vulnerable people are eligible to receive the UK’s second antiviral Paxlovid, which has been added to the PANORAMIC national study
Category: Government
Latest Government advice, news and guidance relating to COVID-19
Prevalence of COVID-19 remains at high levels across the country
Findings from the final report of the government-backed REACT-1, one of the largest studies into coronavirus (COVID-19) infections in England, have been published today.
UK medics provide training to frontline workers in Malaita Province
Frontline workers on COVID-19 response at Atoifi and Kilu’ufi hospitals in Malaita province attended a two-week training delivered by UK Emergency Medical Team.
New guidance sets out how to live safely with COVID-19
The UK Health Security Agency (UKHSA) has today published updated guidance to support the next stage of the COVID-19 pandemic.
Changes to COVID-19 testing in England from 1 April
Information on who can access free coronavirus (COVID-19) tests from 1 April 2022 and how to get them.
Over half of pregnant women have now had one or more doses of COVID-19 vaccines
Latest UK Health Security Agency (UKHSA) data shows that 53.7% of pregnant women in England have been vaccinated with at least one dose of coronavirus (COVID-19) vaccine.
New law to resolve remaining COVID-19 commercial rent debts now in place
A new law is now in place to help resolve certain remaining commercial rent debts.
UK emergency medical team on COVID-19 response ready for provincial deployment in Solomon Islands
The UK Emergency Medical Team on COVID-19 response will deploy to Malaita and Western Provinces in the Solomon Islands on 23 March 2022.
Regulatory approval of Evusheld (tixagevimab/cilgavimab)
Information for healthcare professionals and the public about Evusheld
Evusheld approved to prevent COVID-19 in people whose immune response is poor
The decision to grant approval for this treatment was endorsed by the government’s independent expert scientific advisory body, the Commission on Human Medicines, after carefully reviewing the evidence.